Skip to main content
OpenTrials

Clinical trial condition

Recurrent Thyroid Cancer

Explore clinical trials studying Recurrent Thyroid Cancer. Study availability and eligibility vary by location and protocol.

15 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Thyroid Cancer trial results

Completed

Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer

NCT01723202

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +15 more
Locations
  • University of California, San Diego San Diego, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Massachusetts General Hospital, Harvard Medical School Boston, Massachusetts, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details
Completed

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

NCT02152137

Conditions
Anaplastic Thyroid Cancer, Carcinoma, Endocrine Gland Neoplasms, +10 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 253 locations
View Trial Details
Completed

Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

NCT00104871

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +17 more
Locations
  • University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View Trial Details
Completed

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131

NCT00085293

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +18 more
Locations
  • University of Colorado at Denver Aurora, Colorado, United States
  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer

NCT01502410

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +31 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 92 locations
View Trial Details

Related conditions